We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Turnover Technique Aids Hand Tendon Reconstruction

By HospiMedica International staff writers
Posted on 24 Jul 2013
A novel tendon lengthening technique avoids the additional morbidity and complications associated with grafting, transfers, and two stage reconstructions. More...


Researchers at St. George's Healthcare NHS Trust (London, United Kingdom) have developed a turnover lengthening technique for hand tendons that is quick, simple, and reproducible for defects not exceeding 3 to 4 centimeters, provides a means of immediate one stage reconstruction, does not involve secondary donor site morbidity, and does not compromise salvage by tendon transfer and/or two-stage reconstruction in cases of failure.

The technique involves access to the injured tendon and severed ends by careful and atraumatic surgical technique. The donor tendon stump is incised in an “L-shape” fashion, allowing longitudinal splitting of approximately 50% of the tendon circumference; sufficient tendon length must be ensured to bridge the gap after 180° of tendon turnover. The length of tendon turnover donor stump is calculated bearing in mind that tendon splitting should stop 0.5–1.0 cm from the lacerated end so that enough, yet not too much of the tendon substance is left for pedicle reinforcement at the point of tendon turnover with appropriate sutures.

The exposed tendon core of the donor site and turnover stump are then tubularized with continuous epitendonous approximating sutures, and the tubularized tendon turnover stump is anastomosed to the recipient tendon stump to reinforce the turnover site, reinstate epitendonous continuity, reduce adhesion formation and obviate the added cost and unpredictability of acellular dermal matrix use. The authors stress that decreasing the tendon cross-sectional diameter by 50% is biomechanically safe, and in keeping with current literature. The study was published in the July 2013 issue of Journal of Plastic, Reconstructive & Aesthetic Surgery.

“The technique has successfully been applied to the repair of several cases, including a case of attritional flexor and traumatic extensor tendon rupture in two presented patients where primary tenorrhaphy was not possible,” concluded study coauthor, consultant plastic surgeon Sonja Cerovac, MD. “In both cases a good postoperative outcome was achieved, as the patients were happy having returned back to normal activities of daily living such that they were discharged 12 weeks postoperatively.”

Related Links:

St. George's Healthcare NHS Trust



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.